Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open‐label studies
Belkoff, L., Brock, G., Carrara, D., Neijber, A., Ando, M., Mitchel, J.
Published in Andrologia (01.02.2018)
Published in Andrologia (01.02.2018)
Get full text
Journal Article
A new 2% testosterone gel formulation: a comparison with currently available topical preparations
Arver, S., Stief, C., de la Rosette, J., Jones, T. H., Neijber, A., Carrara, D.
Published in Andrology (Oxford) (01.05.2018)
Published in Andrology (Oxford) (01.05.2018)
Get full text
Journal Article
Immunological changes following blue light cystoscopy with hexaminolevulinate in bladder cancer
Elbæk, S.K., Young-Halvorsen, K., Neijber, A., Jensen, J.B., Dyrskjøt, L.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
A0431 - Immunological changes following blue light cystoscopy with hexaminolevulinate in bladder cancer
Elbæk, S.K., Young-Halvorsen, K., Neijber, A., Jensen, J.B., Dyrskjøt, L.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
848 Degarelix is well tolerated and effective for the treatment of prostate cancer: Results from a phase III study in China
Xie, L, Bosnyák, Z, Sun, Y, Malmberg, A, Neijber, A, Fen, W.X
Published in European urology supplements : official journal of the European Association of Urology (01.03.2016)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2016)
Get full text
Journal Article
Chronic Urticaria: A Swedish Registry-based Cohort Study on Population, Comorbidities and Treatment Characteristics
Tayefi, Mahsa, Bradley, Maria, Neijber, Anders, Fastberg, Alexander, Ceynowa, Dylan, Eriksson, Margareta
Published in Acta dermato-venereologica (04.01.2022)
Published in Acta dermato-venereologica (04.01.2022)
Get full text
Journal Article
559 Association between baseline cardiovascular (CV) status and the development of CV events in prostate cancer (PCa) patients treated with luteinising hormone-releasing hormone (LHRH) agonist versus antagonist: Results of a pooled analysis
Nilsson, J, Borre, M, Bosnyak, Z, Malmberg, A, Davey, P, Neijber, A
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Get full text
Journal Article
975 Greater short-term relief of lower urinary tract symptoms in prostate cancer patients treated with degarelix compared to goserelin/bicalutamide: Results of a pooled analysis
Mason, M, Richaud, P, Bosnyak, Z, Malmberg, A, Neijber, A
Published in European urology supplements : official journal of the European Association of Urology (01.04.2014)
Published in European urology supplements : official journal of the European Association of Urology (01.04.2014)
Get full text
Journal Article
565 Factors predicting the off-treatment duration during intermittent androgen deprivation (IAD) therapy with degarelix in prostate cancer
Abrahamsson, P-A, Boccon-Gibod, L, De Jong, I.J, Morote, J, Malmberg, A, Neijber, A, Albers, P
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Published in European urology supplements : official journal of the European Association of Urology (01.04.2015)
Get full text
Journal Article
LONG-TERM SAFETY AND TOLERABILITY OF DAPOXETINE FOR THE TREATMENT OF MEN WITH PREMATURE EJACULATION
Shabsigh, R., Broderick, G., Miloslavsky, M., Bull, S., Nilsson-Neijber, A.
Published in European urology supplements : official journal of the European Association of Urology (01.04.2006)
Published in European urology supplements : official journal of the European Association of Urology (01.04.2006)
Get full text
Journal Article